Immunoblot analysis using NOX4 specific antibody shows that NOX4 is predominantly up regulated in the mitochondrial fraction in CIS-sensitive cells under doxorubicin treatment in the absence of Mcl-1 (Figure 5G, right panel). The gene discussed is NOX4; the disease is in situ carcinoma.